High‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first recurrence of Ewing sarcoma
References
Additional references
Al‐Faris N, Al Harbi T, Goia C, Pappo A, Doyle J, Gassas A. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?. Pediatric Blood and Cancer 2007;49(2):190‐5.
Bacci G, Toni A, Avella M, Manfrini M, Sudanese A, Ciaroni D, et al. Long‐term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer 1989;63(8):1477‐86.
Bacci G, Ferrari S, Longhi A, Donati D, De Paolis M, Forni C, et al. Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. Annals of Oncology 2003;14(11):1654‐9.
Barker LM, Pendergrass TW, Sanders JE, Hawkins DS. Survival after recurrence of Ewing's sarcoma family of tumors. Journal of Clinical Oncology 2005;23(19):4354‐62.
Burdach S, Meyer‐Bahlburg A, Laws HJ, Haase R, van Kaik B, Metzner B, et al. High‐dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total‐body irradiation. Journal of Clinical Oncology 2003;21(16):3072‐8.
Cotterill SJ, Ahrens S, Paulussen M, Jürgens HF, Voûte PA. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. Journal of Clinical Oncology 2000;18(17):3108‐14.
Delattre O, Zucman J, Melot T. The Ewing family of tumors ‐ a subgroup of small‐round‐cell tumors defined by specific chimeric transcripts. New England Journal of Medicine 1994;331:294‐9.
Gardner SL, Carreras J, Boudreau C, Camitta BM, Adams RH, Chen AR, et al. Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. Bone Marrow Transplantation 2008;42(10):867‐72.
Hanna SA, David LA, Gikas PD, Tindall AJ, Cannon SR, Briggs TW. Very late local recurrence of Ewing's sarcoma ‐ can you ever say 'cured'? A report of two cases and literature review. Annals of the Royal College of Surgeons of England 2008;90(7):W12‐5.
Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org2011.
Ladenstein R, Pötschger U, Le Deley MC, Whelan J, Paulussen M, Oberlin O, et al. Primary disseminated multifocal Ewing sarcoma: results of the Euro‐EWING 99 trial. Journal of Clinical Oncology 2010;28(20):3284‐91.
Lin PP, Jaffe N, Herzog CE, Costelloe CM, Deavers MT, Kelly JS, et al. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma. Cancer 2007;109(3):603‐11.
McTiernan A, Driver D, Michelagnoli MP, Kilby AM, Whelan JS. High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours. Annals of Oncology 2006;17(8):1301‐5.
Kremer LCM, van Dalen EC, Moher D, Caron HN. Cochrane Childhood Cancer Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs))2010, issue 12.
Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17:2815‐34.
Potratz J, Dirksen U, Jürgens H, Craft A. Ewing sarcoma: clinical state‐of‐the‐art. Pediatric Hematology and Oncology 2012;29(1):1‐11.
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Rodríguez‐Galindo C, Liu T, Krasin MJ, Wu J, Billups CA, Daw NC, et al. Analysis of prognostic factors in Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies. Cancer 2007;110(2):375‐84.
Rodríguez‐Galindo C, Navid F, Liu T, Billups CA, Rao BN, Krasin MJ, et al. Prognostic factors for local and distant control in Ewing sarcoma family of tumors. Annals of Oncology 2008;19(4):814‐20.
Shankar AG, Ashley S, Craft AW, Pinkerton CR. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma. Medical and Pediatric Oncology 2003;40(3):141‐7.
Stahl M, Ranft A, Paulussen M, Bölling T, Vieth V, Bielack S, et al. Risk of recurrence and survival after relapse in patients with Ewing sarcoma. Pediatric Blood and Cancer 2011;57(4):549‐53.
van den Berg H, Kroon HM, Slaar A, Hogendoorn P. Incidence of biopsy‐proven bone tumors in children: a report based on the Dutch pathology registration "PALGA". Journal of Pediatric Orthopaedics 2008;28(1):29‐35.
